Literature DB >> 23706185

Ossified ligamentum flavum causing spinal cord compression in a patient with acromegaly.

Richard F Schmidt1, Ira M Goldstein, James K Liu.   

Abstract

Acromegaly is a relatively rare neuroendocrine disorder associated with diffuse hypertrophy of bony and soft tissues due to growth hormone hypersecretion from a pituitary adenoma. Acromegaly can also cause numerous pathological changes in the spine, including degenerative osteoarticular disease, axial arthropathy, spinal stenosis, vertebral fracture and diffuse idiopathic skeletal hyperostosis (Forestier's disease). Ossified ligamentum flavum (OLF) is a rare disorder that often presents as thoracic spinal stenosis, but to our knowledge has never been described in patients with acromegaly. Previously, no link has been established between these two entities. We present, to our knowledge, the first reported case of OLF in a patient with acromegaly who presented with thoracic spinal cord compression. OLF is a potential spinal manifestation of acromegaly and should be considered in the differential diagnosis of spinal stenosis or spinal cord compression in the context of growth hormone hypersecretion.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acromegaly; Axial arthropathy; Diffuse idiopathic skeletal hyperostosis; Myelopathy; Ossified ligamentum flavum; Spinal stenosis; Vertebral fracture

Mesh:

Year:  2013        PMID: 23706185     DOI: 10.1016/j.jocn.2012.10.033

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  2 in total

1.  Ossification of the Ligamentum Flavum in a Nineteenth-Century Skeletal Population Sample from Ireland: Using Bioarchaeology to Reveal a Neglected Spine Pathology.

Authors:  Jonny Geber; Niels Hammer
Journal:  Sci Rep       Date:  2018-06-18       Impact factor: 4.379

2.  Acromegaly presenting with myelopathy due to ossification of posterior longitudinal ligament: a case report.

Authors:  Daisuke Kamakura; Katsunori Fukutake; Kazumasa Nakamura; Shintaro Tsuge; Keiji Hasegawa; Naobumi Tochigi; Akihito Wada; Tetsuo Mikami; Hiroshi Takahashi
Journal:  BMC Musculoskelet Disord       Date:  2021-04-14       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.